| 24 May 2026 |
HGH Fragment 176-191 |
6.5 |
2mg |
2.2mg |
+8.3% |
97.21% |
Lab E |
| 24 May 2026 |
Humanin |
4.2 |
50mg |
45.4mg |
-9.1% |
96.02% |
Lab D |
| 24 May 2026 |
P21 |
4.0 |
10mg |
10.8mg |
+7.7% |
96.02% |
Lab D |
| 24 May 2026 |
Pancragen |
4.5 |
15mg |
18.7mg |
+24.3% |
98.05% |
Lab B |
| 24 May 2026 |
Primobolan E |
4.5 |
300mg/ml |
342.3mg/ml |
+14.1% |
99.93% |
Lab A |
| 24 May 2026 |
SR9009 |
5.5 |
10mg |
12.1mg |
+20.5% |
97.46% |
Lab G |
| 23 May 2026 |
Semaglutide Oral |
6.6 |
10mg |
10.5mg |
+5.1% |
95.60% |
Lab E |
| 23 May 2026 |
Test Enanthate |
6.2 |
100mg/ml |
123.2mg/ml |
+23.2% |
97.49% |
Lab E |
| 21 May 2026 |
Alprostadil |
5.6 |
20mg |
20.2mg |
+0.9% |
98.32% |
Lab A |
| 21 May 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.0 |
50mg |
48.2mg |
-3.7% |
97.86% |
Lab G |
| 20 May 2026 |
Blend 500 (Tren E/Mast E) |
7.8 |
300mg/ml |
319.8mg/ml |
+6.6% |
99.01% |
Lab F |
| 20 May 2026 |
KPV Oral |
6.5 |
100mg |
114.7mg |
+14.7% |
99.70% |
Lab G |
| 29 Jan 2026 |
Retatrutide 30mg Pen Kit |
4.6 |
5mg |
4.9mg |
-2.9% |
96.87% |
Lab G |
| 26 Jan 2026 |
Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) |
7.3 |
100mg/ml |
89.2mg/ml |
-10.8% |
96.26% |
Lab C |
| 19 Jan 2026 |
Retatrutide |
7.5 |
5mg |
5.1mgwebsite |
5.63mg |
+10.2% |
RT5314 |
| 19 Jan 2026 |
SNAP-8 |
5.0 |
5mg |
5.2mg |
+3.2% |
95.69% |
Lab B |
| 9 Jan 2026 |
ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 |
4.0 |
500g |
548.3g |
+9.7% |
97.99% |
Lab F |
| 9 Jan 2026 |
Halotestin (Fluoxymesterone) |
4.0 |
25mg |
24.5mg |
-1.9% |
95.50% |
Lab D |
| 9 Jan 2026 |
Superdrol |
8.1 |
25mg |
22.0mg |
-12.0% |
95.89% |
Lab G |
| 7 Jan 2026 |
Ostarine (MK-2866) |
4.0 |
25mg |
26.8mg |
+7.0% |
97.51% |
Lab A |
| 6 Jan 2026 |
Sustanon 250 |
9.2 |
200mg/ml |
211.5mg/ml |
+5.8% |
97.66% |
Lab G |
| 29 Dec 2025 |
Benzaldehyde CAS 100-52-7 |
5.7 |
1g |
1.0g |
+2.1% |
99.97% |
Lab C |
| 29 Dec 2025 |
BPC157 10mg + TB500 10mg Blend |
7.0 |
10mg |
12.2mg |
+22.0% |
96.98% |
Lab A |
| 29 Dec 2025 |
Chonluten |
7.6 |
30mg |
32.2mg |
+7.4% |
95.72% |
Lab D |
| 29 Dec 2025 |
T3 (Liothyronine) |
6.7 |
20mg |
24.6mg |
+23.0% |
96.45% |
Lab A |
| 12 Dec 2025 |
PE 22-28 |
7.3 |
50mg |
62.0mg |
+24.0% |
98.91% |
Lab E |
| 5 Dec 2025 |
MT-1 |
9.4 |
2mg |
2.0mg |
-1.9% |
97.79% |
Lab A |
| 23 Nov 2025 |
Clomid |
6.5 |
10mg |
9.3mg |
-7.2% |
99.77% |
Lab E |
| 14 Nov 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.2 |
2mg |
1.8mg |
-8.9% |
99.51% |
Lab G |
| 5 Nov 2025 |
Arimidex (Anastrozole) |
5.9 |
20mg |
22.5mg |
+12.5% |
95.62% |
Lab F |
| 5 Nov 2025 |
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 |
4.0 |
10g |
8.5g |
-14.7% |
98.70% |
Lab E |
| 9 Oct 2025 |
HMG |
10.0 |
30mg |
30.5mg |
+1.8% |
96.07% |
Lab F |
| 3 Oct 2025 |
AOD9604 |
6.2 |
20mg |
18.8mg |
-6.0% |
99.75% |
Lab A |
| 4 Sep 2025 |
Tirzepatide |
7.3 |
30mg |
(no batch claim) |
28.1mg |
-6.3% |
(no batch ID) |
| 11 Aug 2025 |
Tirzepatide |
6.6 |
60mg |
(no batch claim) |
65.7mg |
+9.5% |
(no batch ID) |
| 20 Mar 2025 |
Retatrutide |
7.2 |
10mg |
(no batch claim) |
11.86mg |
+18.6% |
2024-10-21 |
| 20 Mar 2025 |
Ipamorelin |
3.7 |
2mg |
(no batch claim) |
1.44mg |
-28.0% |
2024-01-05 |
| 20 Mar 2025 |
Tirzepatide |
7.8 |
10mg |
(no batch claim) |
11.4mg |
+14.0% |
2024-07-23 |